Latham & Watkins represented Innocoll Biotherapeutics in the transaction. Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, has announced the successful...
Innocoll Biotherapeutics’ $125 Million Term Loan Facility
Cast & Crew’s Acquisition of Backstage Holdings
Latham & Watkins represented Cast & Crew in the transaction while Goodwin advised TA Associates and Backstage Holdings. Cast & Crew, a leading end-to-end cloud-based platform...
Waldencast’s $1.2 Billion Business Combination With Obagi and Milk Makeup
Skadden, Arps, Slate, Meagher & Flom represented Waldencast. Latham & Watkins, working alongside Conyers and Nixon Peabody, represented Obagi, and Goodwin Procter represented Milk Makeup in...
Tecno Fast’s Acquisition of Triumph Modular
Claro & Cia and Foley Hoag advised Tecno Fast S.A. Latham & Watkins represented Triumph Modular in the transaction . Triumph Modular, a leading provider of...
Rivian Automotive’s Initial Public Offering
Latham & Watkins advised Rivian Automotive, while Skadden, Arps, Slate, Meagher & Flom advised the underwriters in the Initial Public Offering. Rivian Automotive, Inc. has announced its...
Agenus’ Launch of SaponiQx
Latham & Watkins represented Agenus Inc. in the transaction. Agenus Inc. (Agenus), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines...
Intuit’s $12 Billion Acquisition of Mailchimp
King & Spalding advised Mailchimp on the deal, while Latham & Watkins represented Intuit. McDermott Will & Emery represented co-founder and co-owner of Mailchimp. Mailchimp, a world-class,...